PASADENA, Calif.--(BUSINESS WIRE)--Deep 6 AI, an artificial intelligence (AI) company focused on accelerating patient recruitment for clinical trials, today announced the addition of Jason Attanucci as Vice President of Life Sciences to the growing Deep 6 AI leadership team. In this newly created role, Jason will introduce the Deep 6 AI Clinical Trials Acceleration Software (CTAS) platform to the life sciences eClinical market.
“Deep 6’s ability to precision-match patients to clinical trials, using AI and natural language processing is unparalleled in the industry. I’m thrilled to offer this unique data-driven solution that connects all clinical trial stakeholders, in support of our mission to help bring new treatments to patients, faster.”
Jason brings nearly 20 years of successful life science leadership to Deep 6 AI. Most recently, Jason served as Global Head of Customer Solutions and Sr. Director of Sales and Partnerships at BioFortis, a clinical research technology solutions provider. Previous experience includes global and national leadership positions at Bioclinica, Medidata Solutions, and GenoLogics Life Sciences Software Inc.
Jason holds a B.S. in both microbiology and molecular biology from the University of Pittsburgh, and studied Immunology at University of Pittsburgh School of Medicine.
“Jason is a great addition to our leadership team.” said Wout Brusselaers, CEO of Deep 6 AI. “His deep understanding of the eClinical market and singular focus on value delivery for our clients will help bring the benefits of Deep 6 AI’s cutting-edge software solution to biopharmaceutical sponsors and contract research organizations around the world.”